IGF1R and Parkinson disease: Moreover, E2 reduced by 25% the synergism and increased by 36% the antagonism of IGF1R with genes involved in amyotrophic lateral sclerosis and Alzheimer's, Huntington's, Parkinson's and prion diseases.